AU5540800A - Nucleic and proteinic acids corresponding to human gene abc1 - Google Patents

Nucleic and proteinic acids corresponding to human gene abc1 Download PDF

Info

Publication number
AU5540800A
AU5540800A AU55408/00A AU5540800A AU5540800A AU 5540800 A AU5540800 A AU 5540800A AU 55408/00 A AU55408/00 A AU 55408/00A AU 5540800 A AU5540800 A AU 5540800A AU 5540800 A AU5540800 A AU 5540800A
Authority
AU
Australia
Prior art keywords
nucleic acid
abc1
nucleotide
polypeptide
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55408/00A
Other languages
English (en)
Inventor
Isabelle Arnould-Reguigne
Gerd Assmann
H. Bryan Brewer Jr.
Patrice Denefle
Nicolas Duverger
Harald Funke
Cendrine Lemoine
Laurent Naudin
Catherine Prades
Marie-Francoise Rosier-Montus
Stephan Rust
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907684A external-priority patent/FR2795091B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU5540800A publication Critical patent/AU5540800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
AU55408/00A 1999-06-17 2000-06-08 Nucleic and proteinic acids corresponding to human gene abc1 Abandoned AU5540800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9907684 1999-06-17
FR9907684A FR2795091B1 (fr) 1999-06-17 1999-06-17 Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic
US14712899P 1999-08-04 1999-08-04
US60147128 1999-08-04
PCT/FR2000/001595 WO2000078970A1 (fr) 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain

Publications (1)

Publication Number Publication Date
AU5540800A true AU5540800A (en) 2001-01-09

Family

ID=26234994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55408/00A Abandoned AU5540800A (en) 1999-06-17 2000-06-08 Nucleic and proteinic acids corresponding to human gene abc1

Country Status (11)

Country Link
EP (1) EP1190063A1 (fr)
JP (1) JP2003503026A (fr)
KR (1) KR20020012279A (fr)
AU (1) AU5540800A (fr)
BR (1) BR0011724A (fr)
CA (1) CA2375771A1 (fr)
HU (1) HUP0204524A2 (fr)
IL (1) IL147071A0 (fr)
MX (1) MXPA01013062A (fr)
NO (1) NO20016089L (fr)
WO (1) WO2000078970A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2367955C (fr) 1999-03-15 2009-05-19 University Of British Columbia Methodes et reactifs permettant de moduler les taux de cholesterol
AU2002210636A1 (en) * 2000-10-31 2002-05-15 Aventis Pharma S.A. Polymorphic sequences of the human ABCA1 gene, their uses, detection methods and kits
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
NZ556415A (en) * 2002-01-02 2009-02-28 Genentech Inc Compositions and methods for the diagnosis and treatment of glioma tumor
CN112442114A (zh) * 2019-08-29 2021-03-05 渥太华Hdl药物研发公司 一种多肽及其应用

Also Published As

Publication number Publication date
WO2000078970A1 (fr) 2000-12-28
NO20016089D0 (no) 2001-12-13
MXPA01013062A (es) 2002-06-04
IL147071A0 (en) 2002-08-14
EP1190063A1 (fr) 2002-03-27
BR0011724A (pt) 2002-03-26
NO20016089L (no) 2002-02-15
JP2003503026A (ja) 2003-01-28
HUP0204524A2 (hu) 2003-04-28
CA2375771A1 (fr) 2000-12-28
KR20020012279A (ko) 2002-02-15

Similar Documents

Publication Publication Date Title
EP1100895B1 (fr) Methodes et reactifs permettant de moduler les taux de cholesterol
US6759512B1 (en) Human neuronal attachment factor-1
KR100640265B1 (ko) Ｌｙ6ｈ 유전자
US6225451B1 (en) Chromosome 11-linked coronary heart disease susceptibility gene CHD1
US20050158784A1 (en) Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
EP1096012A1 (fr) Acides nucléiques correspondant au gène ABC1 humain et leur application thérapeutique et diagnostique
AU5540800A (en) Nucleic and proteinic acids corresponding to human gene abc1
EP1213352A1 (fr) Acides nucléiques des gènes humains abca5, abca6, abca9 et abca10, des vecteurs les contenant et leurs utilisations
JPH1084977A (ja) ヒトマクロスカベンジャー受容体
AU785155B2 (en) Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses
US20030087246A1 (en) Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
US20040191791A1 (en) Novel mutation
ZA200110545B (en) Nucleic and proteinic acids corresponding to human gene ABC1.
US20050136421A1 (en) Methods and reagents for modulating cholesterol levels
US20030108894A1 (en) Novel polypeptide-atp-dependent helicase protein 68 and the polynucleotide encoding said polypeptide
KR20020059645A (ko) 인간 에이비씨1 유전자의 핵산과 이의 치료적 및 진단적적용
JP2002223778A (ja) 慢性腎不全の標的およびマーカーであるｃｒｆｇ−１
US20060063166A1 (en) Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids and uses thereof
JP2004537983A (ja) ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用